by Gary Pepper M.D. | Sep 5, 2016 | diabetes, general health & nutrition, Medical Economics, thyroid cancer
By Gary Pepper, M.D. A survey by metabolism.com reveals that a vast majority of the public believe doctors in the US are overly influenced in their decisions by the pharmaceutical industry. 500 visitors to the website participated in the survey. 419 (84%) answered...
by Gary Pepper M.D. | May 3, 2016 | Hypothyroidism, T3
On April 11, 2016 an article, Doctors Hear Patients’ Calls for New Approaches to Hypothyroidism, appeared in the Wall Street Journal regarding the growing influence of patient preference on treatment selection for hypothyroidism (sluggish thyroid). The article...
by Gary Pepper M.D. | Nov 10, 2015 | hormones, Hypothyroidism, T3, thyroid
According to experts, 10 to 20% of hypothyroid individuals fail to respond completely to T4-only (levothyroxine, Synthroid) treatment. Dr. Anthony Bianco, the president of the American Thyroid Association, and his associates believe this is due to genetic variations...
by Gary Pepper M.D. | Oct 30, 2015 | cancer, thyroid, thyroid cancer
By Gary Pepper, M.D. Last week I posted a few highlights from the just concluded International Thyroid Congress. One of the research papers presented at the meeting generated particular concern. Endocrinologists and scientists at UCLA Medical Center led by Dr. Jerome...
by Gary Pepper M.D. | Oct 25, 2015 | metabolism, T3, thyroid
Update from the 15th International Thyroid Congress, Orlando Florida, October, 2015 By Gary Pepper, M.D. Â Â Â Â I just returned from Orlando, Florida, where I attended the 15th International Thyroid Congress and want to provide a report of my experience, to readers...
